KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $17.1 billion.

  • Elevance Health's Other Accumulated Expenses rose 849.74% to $17.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $17.1 billion, marking a year-over-year increase of 849.74%. This contributed to the annual value of $17.1 billion for FY2025, which is 849.74% up from last year.
  • Elevance Health's Other Accumulated Expenses amounted to $17.1 billion in Q4 2025, which was up 849.74% from $17.1 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Other Accumulated Expenses ranged from a high of $17.2 billion in Q2 2025 and a low of $12.3 billion during Q1 2021
  • For the 5-year period, Elevance Health's Other Accumulated Expenses averaged around $15.4 billion, with its median value being $15.7 billion (2022).
  • As far as peak fluctuations go, Elevance Health's Other Accumulated Expenses surged by 3237.5% in 2021, and later plummeted by 594.49% in 2024.
  • Elevance Health's Other Accumulated Expenses (Quarter) stood at $13.5 billion in 2021, then grew by 15.37% to $15.6 billion in 2022, then increased by 3.3% to $16.1 billion in 2023, then fell by 2.27% to $15.7 billion in 2024, then increased by 8.5% to $17.1 billion in 2025.
  • Its last three reported values are $17.1 billion in Q4 2025, $17.1 billion for Q3 2025, and $17.2 billion during Q2 2025.